KR101997018B1 - 글리코겐-기반 양이온 폴리머 - Google Patents

글리코겐-기반 양이온 폴리머 Download PDF

Info

Publication number
KR101997018B1
KR101997018B1 KR1020147021215A KR20147021215A KR101997018B1 KR 101997018 B1 KR101997018 B1 KR 101997018B1 KR 1020147021215 A KR1020147021215 A KR 1020147021215A KR 20147021215 A KR20147021215 A KR 20147021215A KR 101997018 B1 KR101997018 B1 KR 101997018B1
Authority
KR
South Korea
Prior art keywords
alkyl
amino
group
glycogen
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020147021215A
Other languages
English (en)
Korean (ko)
Other versions
KR20150006414A (ko
Inventor
빈첸초 루소
엘리자 리베라티
니콜라 카졸라
Original Assignee
아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 filed Critical 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이
Publication of KR20150006414A publication Critical patent/KR20150006414A/ko
Application granted granted Critical
Publication of KR101997018B1 publication Critical patent/KR101997018B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/18—Reserve carbohydrates, e.g. glycogen, inulin, laminarin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020147021215A 2012-03-15 2013-02-21 글리코겐-기반 양이온 폴리머 Expired - Fee Related KR101997018B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12159710.8 2012-03-15
EP12159710 2012-03-15
PCT/EP2013/053422 WO2013135471A1 (en) 2012-03-15 2013-02-21 Glycogen-based cationic polymers

Publications (2)

Publication Number Publication Date
KR20150006414A KR20150006414A (ko) 2015-01-16
KR101997018B1 true KR101997018B1 (ko) 2019-07-05

Family

ID=47739282

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147021215A Expired - Fee Related KR101997018B1 (ko) 2012-03-15 2013-02-21 글리코겐-기반 양이온 폴리머

Country Status (29)

Country Link
US (1) US9717801B2 (https=)
EP (1) EP2825565B1 (https=)
JP (1) JP6247234B2 (https=)
KR (1) KR101997018B1 (https=)
CN (2) CN104080812B (https=)
AR (1) AR090307A1 (https=)
AU (1) AU2013231561B2 (https=)
BR (1) BR112014018617A8 (https=)
CA (1) CA2859273C (https=)
CY (1) CY1121829T1 (https=)
DK (1) DK2825565T3 (https=)
EA (1) EA032479B1 (https=)
ES (1) ES2732216T3 (https=)
GE (1) GEP201606581B (https=)
HR (1) HRP20191114T1 (https=)
HU (1) HUE045049T2 (https=)
IL (1) IL233823B (https=)
LT (1) LT2825565T (https=)
ME (1) ME03429B (https=)
MX (1) MX351599B (https=)
PL (1) PL2825565T3 (https=)
PT (1) PT2825565T (https=)
RS (1) RS58985B1 (https=)
SG (2) SG10201607577QA (https=)
SI (1) SI2825565T1 (https=)
SM (1) SMT201900342T1 (https=)
TR (1) TR201909387T4 (https=)
UA (1) UA115135C2 (https=)
WO (1) WO2013135471A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR095937A1 (es) 2013-04-05 2015-11-25 Acraf Potenciador de la solubilidad en agua a base de glucógeno
KR102214865B1 (ko) 2013-04-26 2021-02-15 마이렉서스 바이오테크놀로지스 인코퍼레이티드 파이토글리코겐 나노입자와 이를 제조하는 방법
CA2971830A1 (en) * 2014-12-29 2016-07-07 Bonac Corporation Composition containing nucleic acid molecule stably
CN104558246B (zh) * 2015-01-20 2017-03-01 武汉理工大学 一种叶酸/生物素修饰的壳聚糖材料及其制备方法
DE102015205088C5 (de) * 2015-03-20 2024-09-26 Kuka Deutschland Gmbh Verfahren zum Ermitteln eines Kalibrierungsparameters eines Fahrzeuges sowie Fahrzeug hierzu
JP6872782B2 (ja) * 2016-03-08 2021-05-19 国立大学法人京都大学 カチオン性グルカンナノスフェア、複合体、核酸導入剤及びがん治療剤
WO2017177342A1 (en) * 2016-04-14 2017-10-19 Mirexus Biotechnologies Inc. Anti-infective compositions comprising phytoglycogen nanoparticles
WO2017190248A1 (en) * 2016-05-04 2017-11-09 Mirexus Biotechnologies Inc. Glycogen and phytoglycogen nanoparticles as immunosuppressive compounds, and compositions and methods of use thereof
CN105949344B (zh) * 2016-05-13 2019-05-17 中山大学 一种阳离子超支化多糖衍生物及其在增强血卟啉类光敏剂对肿瘤细胞光毒性方面的应用
WO2019027999A1 (en) * 2017-07-31 2019-02-07 Ohio State Innovation Foundation BIOMIMETIC NANOMATERIALS AND USES THEREOF
US11384161B2 (en) 2018-01-11 2022-07-12 Virginia Tech Intellectual Properties, Inc. Amphiphilic polysaccharides, polysaccharide-based hydrogels, and methods of manufacture
CN116178587B (zh) * 2023-02-28 2025-04-11 江南大学 一种季铵盐化糖原、复合抗菌水凝胶及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011504457A (ja) * 2007-11-08 2011-02-10 大塚製薬株式会社 核酸複合体、及び核酸送達用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904370D0 (en) 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
IT1255488B (it) 1992-08-04 1995-11-06 Angelini Francesco Ist Ricerca Polisaccaridi del glicogeno
US7144713B1 (en) * 1995-10-02 2006-12-05 Emd Biosciences, Inc. Method for precipitating nucleic acid with visible carrier
GB9600272D0 (en) 1996-01-06 1996-03-06 Univ Nottingham Polymers
US6106858A (en) * 1997-09-08 2000-08-22 Skyepharma, Inc. Modulation of drug loading in multivescular liposomes
WO2002100435A1 (en) 2001-06-11 2002-12-19 Centre Hospitalier Universitaire De Montreal Compositions and methods for enhancing nucleic acid transfer into cells
US20030147958A1 (en) 2002-01-29 2003-08-07 Cheol-Hee Ahn Biodegradable multi-block copolymers of poly(amino acid)s and poly(ethylene glycol) for the delivery of bioactive agents
AU2003220161A1 (en) 2002-03-12 2003-09-29 Nitto Denko Corporation Vector for transfection of eukaryotic cells
WO2005094894A1 (ja) 2004-03-31 2005-10-13 Medgel Corporation 細胞に核酸を導入するための製剤
US8108158B2 (en) 2005-09-28 2012-01-31 Adrian H. Hetzel Electro-hydraulic timed angle controlled joint simulation torque calibration, certification and analysis device
CN101235098A (zh) * 2008-01-09 2008-08-06 浙江大学 功能性植物多糖的修饰方法
WO2010072627A1 (en) * 2008-12-22 2010-07-01 Unilever Plc Laundry compositions
BRPI0923570A2 (pt) * 2008-12-22 2016-08-23 Unilever Nv composição detergente líquida, e, método para proporcionar maciez a um artigo de tecido
EP2428578B1 (en) * 2009-05-08 2016-03-23 Ezaki Glico Co., Ltd. Glucuronic acid-containing glucan, process for production of same, and use of same
EP2275085A1 (en) * 2009-07-07 2011-01-19 University of Rostock Biodegradable copolymer suitable for delivering nucleic acid materials into cells
CN102068698A (zh) * 2009-11-24 2011-05-25 深圳先进技术研究院 纳米疫苗及其制备方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011504457A (ja) * 2007-11-08 2011-02-10 大塚製薬株式会社 核酸複合体、及び核酸送達用組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Colloids and Surfaces A. (2006) 289, 1-3, 193-199

Also Published As

Publication number Publication date
CN107236052B (zh) 2019-09-24
WO2013135471A1 (en) 2013-09-19
MX2014010698A (es) 2015-03-10
AR090307A1 (es) 2014-11-05
RS58985B1 (sr) 2019-08-30
IL233823A0 (en) 2014-09-30
SG10201607577QA (en) 2016-11-29
HK1203984A1 (en) 2015-11-06
PT2825565T (pt) 2019-07-10
BR112014018617A2 (https=) 2017-06-20
EA201491613A1 (ru) 2014-12-30
JP2015510020A (ja) 2015-04-02
CA2859273C (en) 2020-04-14
CN107236052A (zh) 2017-10-10
DK2825565T3 (da) 2019-06-24
EP2825565A1 (en) 2015-01-21
EA032479B1 (ru) 2019-06-28
EP2825565B1 (en) 2019-04-03
US9717801B2 (en) 2017-08-01
ME03429B (me) 2020-01-20
JP6247234B2 (ja) 2017-12-13
BR112014018617A8 (pt) 2017-07-11
IL233823B (en) 2018-05-31
SG11201403816YA (en) 2014-08-28
US20140378532A1 (en) 2014-12-25
SI2825565T1 (sl) 2019-08-30
GEP201606581B (en) 2016-11-25
CN104080812B (zh) 2017-06-27
AU2013231561B2 (en) 2017-06-08
KR20150006414A (ko) 2015-01-16
CY1121829T1 (el) 2020-07-31
UA115135C2 (uk) 2017-09-25
SMT201900342T1 (it) 2019-07-11
ES2732216T3 (es) 2019-11-21
LT2825565T (lt) 2019-07-10
HUE045049T2 (hu) 2019-12-30
HRP20191114T1 (hr) 2019-09-20
CA2859273A1 (en) 2013-09-19
PL2825565T3 (pl) 2019-10-31
CN104080812A (zh) 2014-10-01
TR201909387T4 (tr) 2019-07-22
AU2013231561A1 (en) 2014-07-10
MX351599B (es) 2017-10-20

Similar Documents

Publication Publication Date Title
KR101997018B1 (ko) 글리코겐-기반 양이온 폴리머
Muddineti et al. Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells
Gao et al. Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency
Khan et al. Polysaccharide gene transfection agents
CN103110954B (zh) 胆固醇修饰的生物可降解聚阳离子载体及制备方法和用途
Jiang et al. Chitosan-graft-spermine as a gene carrier in vitro and in vivo
EP2903651B1 (en) Carboxylated polyamine derivatives as transfection reagents
WO2009036022A1 (en) Enhancement of polysaccharide-mediated nucleic acid delivery
Jana et al. Synthesis of a carboxymethylated guar gum grafted polyethyleneimine copolymer as an efficient gene delivery vehicle
US9572895B2 (en) Multiplexed supramolecular assemblies for non-viral delivery of genetic material
CN103351597A (zh) 可还原聚（酰胺乙烯亚胺）的可切割修饰以增强核苷酸递送
HK1203984B (en) Glycogen-based cationic polymers
Soradech Linear polyethyleneimine and derivatives as potential biomaterials and excipients for drug delivery
Park et al. Highly Osmotic Oxidized Sucrose-Crosslinked Polyethylenimine for Gene Delivery Systems. Pharmaceutics 2021, 13, 87
Kont et al. The impact of cyclodextrin architecture and charge for optimized nucleic acid delivery: A comparison of monomers, dimers, and polymers
Biswas Cholesterol-grafted chitosan micelles as a nanocarrier system for drug-siRNA co-delivery to the lung cancer cells
Hetti Development of novel biodegradable core-shell nanoparticles as carriers for gene delivery

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20220702

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20220702